From Emollients to Biologicals: Targeting Atopic Dermatitis.

Lorenzo Salvati, Lorenzo Cosmi, Francesco Annunziato

International journal of molecular sciences 2021 Sep 26

filter terms:

Atopic dermatitis (AD) is the most common chronic inflammatory skin disease and significantly impacts patients' lives, particularly in its severe forms. AD clinical presentation varies over the course of the disease, throughout different age groups, and across ethnicities. AD is characterized by a spectrum of clinical phenotypes as well as endotypes. Starting from the current description of AD pathogenesis, this review explores the rationale of approved AD therapies from emollients to biologicals and introduces novel promising drugs.

Citation

Lorenzo Salvati, Lorenzo Cosmi, Francesco Annunziato. From Emollients to Biologicals: Targeting Atopic Dermatitis. International journal of molecular sciences. 2021 Sep 26;22(19)